OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Clinical outcomes
Economics
Model
14 Publications
found
Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.
b
Gut
April 1, 2020
p
Inflammatory Bowel Disease
c
Clinical outcomes
Economics
Model
Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.
b
Lung cancer (Amsterdam, Netherlands)
May 1, 2015
p
Cancer
c
Clinical outcomes
Economics
Model
A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis.
b
Lung cancer (Amsterdam, Netherlands)
December 1, 2013
p
Cancer
c
Clinical outcomes
Economics
Model
The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers.
b
British journal of cancer
March 13, 2012
p
Cancer
c
Clinical outcomes
Economics
Model
Previous Page
1
2
